$9.53
0.030.32%
At Close: -
$9.47
-0.06-0.63%
After Hours: Aug 23, 7:59 PM EDT
15 minutes delayed
Comments
Loading...
Emergent BioSolutions (EBS) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesGovernment TradesShort InterestEmergent BioSolutions (NYSE:EBS) Stock Quotes, Forecast and News Summary
Emergent BioSolutions Stock (NYSE: EBS) stock price, news, charts, stock research, profile.
| Open | $9.65 |
| Close | $9.53 |
| Volume / Avg. | 2.36M / 3.08M |
| Day Range | $9.28 - $10.02 |
| 52 Wk Range | 1.42 - 15.10 |
| Market Cap | $496.25M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NYSE |
| RSI | 50 |
| Short Interest | 8.62% |
| Days to Cover | 1.36 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Emergent Biosolutions Inc
Sector
Health Care
Industry
Biotechnology
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. ...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Emergent BioSolutions (EBS) stock?
You can purchase shares of Emergent BioSolutions (NYSE:EBS) through any online brokerage.
Who are Emergent BioSolutions (EBS) competitors?
Other companies in Emergent BioSolutions’s space includes: KalVista Pharma (NASDAQ:KALV), Valneva (NASDAQ:VALN), Korro Bio (NASDAQ:KRRO), Larimar Therapeutics (NASDAQ:LRMR) and Altimmune (NASDAQ:ALT).
What is the forecast, or price target, for Emergent BioSolutions (EBS) stock?
Emergent BioSolutions has a consensus price target of $29.20.
What is the current price for Emergent BioSolutions (EBS)?
The stock price for Emergent BioSolutions (NYSE: EBS) is $9.47 last updated August 23, 2024 at 7:59 PM EDT.
Does Emergent BioSolutions (EBS) pay a dividend?
There are no upcoming dividends for Emergent BioSolutions.
When is Emergent BioSolutions (NYSE:EBS) reporting earnings?
Emergent BioSolutions’s Q3 earnings are confirmed for Thursday, October 31, 2024.
Is Emergent BioSolutions (EBS) going to split?
There is no upcoming split for Emergent BioSolutions.
What sector and industry does Emergent BioSolutions (EBS) operate in?
Emergent BioSolutions is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.